Early-onset Alzheimer's disease

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Early-onset Alzheimer's disease | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Memory loss, cognitive decline, language problems, disorientation |
| Complications | N/A |
| Onset | Typically before age 65 |
| Duration | Progressive |
| Types | N/A |
| Causes | Genetic mutations, familial history |
| Risks | Genetic predisposition, family history |
| Diagnosis | Clinical assessment, neuroimaging, genetic testing |
| Differential diagnosis | Other dementias, depression, thyroid disorders |
| Prevention | N/A |
| Treatment | Medications, supportive care, cognitive therapy |
| Medication | N/A |
| Prognosis | Progressive decline |
| Frequency | Rare compared to late-onset Alzheimer's |
| Deaths | N/A |
Early-onset Alzheimer's disease (EOAD) is a rare variant of Alzheimer's disease (AD) that is diagnosed in individuals under the age of 65. Distinct from the more prevalent late-onset Alzheimer's, EOAD constitutes approximately 5-10% of all Alzheimer's cases. The disease manifests with similar cognitive and behavioral symptoms as its late-onset counterpart, but its onset at a relatively younger age can have profound social, financial, and psychological impacts on affected individuals and their families.
Characteristics and Symptoms[edit]
Early-onset Alzheimer's generally presents with the same cognitive and behavioral symptoms as those observed in late-onset AD. These can include:
- Memory loss
- Confusion regarding time and place
- Difficulty in completing daily tasks
- Trouble with language
- Loss of judgment
- Mood and personality changes
Genetics and Risk Factors[edit]
Of those diagnosed with EOAD:
- Roughly 60% have a familial history of Alzheimer's.
- Around 13% of cases are passed down in an autosomal dominant inheritance pattern, suggesting a strong genetic component.
- Despite these genetic trends, a majority of EOAD cases do not stem from recognized genetic mutations.
Differences from Late-onset Alzheimer's[edit]
While the cognitive symptoms are consistent between early and late-onset Alzheimer's, there are notable differences:
- Age of Diagnosis: EOAD is diagnosed before age 65, whereas late-onset typically occurs in individuals 65 and older.
- Genetic Predisposition: There's a higher likelihood of a genetic factor in EOAD, especially in families with a history of the disease.
- Progression: Some evidence suggests that EOAD might progress more rapidly than the late-onset form, but this is still a topic of research.
Challenges and Impacts[edit]
Early diagnosis of Alzheimer's in younger individuals can be particularly challenging as memory problems might be misattributed to stress or other common causes. Additionally, the diagnosis can have significant repercussions:
- Professional Life: Diagnosis can disrupt careers, leading to early retirement and associated financial challenges.
- Family Dynamics: Younger families might have to adapt to changing roles, especially if the diagnosed individual is a primary caregiver.
- Social Implications: Stigma associated with the disease can lead to social isolation.
Current Research[edit]
Although much remains to be discovered about EOAD, ongoing research aims to understand its causes, develop early diagnostic tools, and find treatments that can slow or stop its progression.
See Also[edit]
|
This article is a stub You can help WikiMD by registering and expanding it with useful details, internal links, formatting, and categories. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health and wellness encyclopedia. |
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian